Cerulean Pharmaceuticals Secures $1,499,999 New Funding Round

  • Feed Type
  • Date
    10/13/2010
  • Company Name
    Cerulean Pharmaceuticals
  • Mailing Address
    840 Memorial Drive 5th Floor Cambridge, MA 02139
  • Company Description
    Within the field of nanopharmaceuticals, Cerulean Pharma is uniquely focused on a next-generation approach we call Nanobiology. Cerulean’s nanobiology-based drug development is based on a deep understanding of the complex biological microenvironment of human disease combined with engineering therapies on a nanoscale, enabling the creation of breakthrough drugs that optimally target the root causes of disease.
  • Website
    http://www.ceruleanrx.com
  • Transaction Type
    Debt
  • Transaction Amount
    $1,499,999
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy